ATE522808T1 - Verfahren zur bestimmung der aktivierung von leukozyten - Google Patents
Verfahren zur bestimmung der aktivierung von leukozytenInfo
- Publication number
- ATE522808T1 ATE522808T1 AT01980741T AT01980741T ATE522808T1 AT E522808 T1 ATE522808 T1 AT E522808T1 AT 01980741 T AT01980741 T AT 01980741T AT 01980741 T AT01980741 T AT 01980741T AT E522808 T1 ATE522808 T1 AT E522808T1
- Authority
- AT
- Austria
- Prior art keywords
- platelet
- leukocyte activation
- component
- determining
- determining leukocyte
- Prior art date
Links
- 230000004913 activation Effects 0.000 title 1
- 210000000265 leukocyte Anatomy 0.000 title 1
- 210000001772 blood platelet Anatomy 0.000 abstract 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 abstract 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
- 229960005305 adenosine Drugs 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 abstract 1
- 229960002768 dipyridamole Drugs 0.000 abstract 1
- 230000010118 platelet activation Effects 0.000 abstract 1
- 229960000278 theophylline Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/2525—Stabilizing or preserving
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Ecology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0027309.4A GB0027309D0 (en) | 2000-11-08 | 2000-11-08 | Method of measuring measuring platlet activation |
| PCT/GB2001/004946 WO2002039124A1 (en) | 2000-11-08 | 2001-11-08 | Method of measuring platelet activation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE522808T1 true ATE522808T1 (de) | 2011-09-15 |
Family
ID=9902807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01980741T ATE522808T1 (de) | 2000-11-08 | 2001-11-08 | Verfahren zur bestimmung der aktivierung von leukozyten |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7011938B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1332373B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2004513369A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE522808T1 (cg-RX-API-DMAC10.html) |
| AU (2) | AU1252902A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2428224C (cg-RX-API-DMAC10.html) |
| ES (1) | ES2372810T3 (cg-RX-API-DMAC10.html) |
| GB (1) | GB0027309D0 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2002039124A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2392724A (en) * | 2002-09-06 | 2004-03-10 | Ian Stoakes | Methods of and apparatus for blood analysis |
| EP1814563A4 (en) * | 2004-07-26 | 2008-04-16 | Bayer Healthcare Llc | PLATTOCK ACTIVATING MARKERS AS PREDICATORS OF ILLNESSES AND THE RESPONSE TO TREATMENTS AND MONITORING THERAPEUTIC PROGRESS |
| US7811549B2 (en) | 2006-07-05 | 2010-10-12 | Adenobio N.V. | Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| US8021854B2 (en) * | 2007-10-05 | 2011-09-20 | Attila Mady | Method of treating vascular disease |
| US8835104B2 (en) * | 2007-12-20 | 2014-09-16 | Fenwal, Inc. | Medium and methods for the storage of platelets |
| US20090185973A1 (en) * | 2008-01-22 | 2009-07-23 | Adenobio N.V. | Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| US10575515B2 (en) | 2010-05-04 | 2020-03-03 | The General Hospital Corporation | Methods and compositions for preserving tissues and organs |
| WO2012139017A1 (en) | 2011-04-07 | 2012-10-11 | Fenwal, Inc. | Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates |
| ES2968371T3 (es) | 2013-10-10 | 2024-05-09 | Eastern Virginia Medical School | Derivados de 4-((2-hidroxi-3-metoxibencil)amino) bencenosulfonamida como inhibidores de la 12-lipoxigenasa |
| JP6687601B2 (ja) * | 2014-08-07 | 2020-04-22 | ザ ジェネラル ホスピタル コーポレイション | 全血サンプルの安定化 |
| US10908171B2 (en) | 2016-07-12 | 2021-02-02 | EMULATE, Inc. | Additive channels |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08220094A (ja) * | 1995-02-08 | 1996-08-30 | Dai Ichi Pure Chem Co Ltd | 血漿中ｇｍｐ−１４０の測定法 |
| FR2731277A1 (fr) * | 1995-03-02 | 1996-09-06 | Benveniste Jacques | Procedes et appareil pour faciliter la purification, le comptage et la mesure de l'activation des leucocytes sanguins |
| US5817519A (en) * | 1995-12-28 | 1998-10-06 | Bayer Corporation | Automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples |
| US6309888B1 (en) * | 1998-09-04 | 2001-10-30 | Leuven Research & Development Vzw | Detection and determination of the stages of coronary artery disease |
-
2000
- 2000-11-08 GB GBGB0027309.4A patent/GB0027309D0/en not_active Ceased
-
2001
- 2001-11-08 AT AT01980741T patent/ATE522808T1/de not_active IP Right Cessation
- 2001-11-08 CA CA2428224A patent/CA2428224C/en not_active Expired - Fee Related
- 2001-11-08 ES ES01980741T patent/ES2372810T3/es not_active Expired - Lifetime
- 2001-11-08 WO PCT/GB2001/004946 patent/WO2002039124A1/en not_active Ceased
- 2001-11-08 AU AU1252902A patent/AU1252902A/xx active Pending
- 2001-11-08 AU AU2002212529A patent/AU2002212529B2/en not_active Ceased
- 2001-11-08 EP EP01980741A patent/EP1332373B1/en not_active Expired - Lifetime
- 2001-11-08 JP JP2002541398A patent/JP2004513369A/ja active Pending
- 2001-11-08 US US10/415,336 patent/US7011938B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7011938B2 (en) | 2006-03-14 |
| EP1332373A1 (en) | 2003-08-06 |
| US20040038997A1 (en) | 2004-02-26 |
| ES2372810T3 (es) | 2012-01-26 |
| AU2002212529B2 (en) | 2006-08-10 |
| EP1332373B1 (en) | 2011-08-31 |
| CA2428224A1 (en) | 2002-05-16 |
| JP2004513369A (ja) | 2004-04-30 |
| GB0027309D0 (en) | 2000-12-27 |
| CA2428224C (en) | 2010-04-27 |
| WO2002039124A1 (en) | 2002-05-16 |
| AU1252902A (en) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI905725L (fi) | Reagenssi ja sitä käyttävä menetelmä vähintään yhden leukosyyttialapopulaation määrittämiseksi kokoverestä automaattisella virtaussolulaskennalla | |
| DE69011198D1 (de) | Verfahren zur Differenzierung von Leukozyten mit Hilfe eines Durchflusszellmessgerätes. | |
| DE3853671D1 (de) | Reagens und Verfahren zur Messung von Leukozyten und Hämoglobin im Blut. | |
| DE69022786D1 (de) | Verfahren zur Bestimmung der Konzentration von Glucose. | |
| EP1212613A4 (en) | HEMATOLOGICAL CONTROL AND SYSTEM FOR HEMATOLOGIC MUCH PARAMETER MEASUREMENTS | |
| DE60033380D1 (de) | Verfahren zur quantifizierung der zahl von leukozyten in einer blutprobe | |
| FI915150A7 (fi) | Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi | |
| DE69434942D1 (de) | Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben | |
| DE3587036D1 (de) | Verfahren und reagenziensystem zur differentiellen bestimmung vierer populationen von leukozyten. | |
| ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
| DE3887694D1 (de) | Vorrichtung zur bestimmung der koagulationszeit einer blutprobe. | |
| ATE78097T1 (de) | Verfahren zur bestimmung von mimitopen. | |
| DE3677618D1 (de) | Gerinnungsmittel zur trennung von serum oder plasma aus vollblut zur verwendung in blutuntersuchungsmethoden. | |
| AU1252902A (en) | Method of measuring platelet activation | |
| DE69731504D1 (de) | Reagenz und Verfahren zur Freisetzung und Bestimmung von Blei in biologischen Matrices | |
| DE3851923D1 (de) | Reagenz zur Retikulozytenzählung mittels Durchflusszytometrie. | |
| DE69122752D1 (de) | Verfahren und Vorrichtung zur Bestimmung der Gerinnungszeit von Blut und Plasma | |
| BR9406223A (pt) | Método para determinar em uma amostra a atividade funcional de um componente da coagulação sanguinea método para diagnosticar um disturbio da coagulação/anticoagulação sanguinea preparado de anticorpo linhagem celular uso de fator v subunidades ou fragmentos do mesmo tendo atividade anticoagulante na forma de cofator par apc prepraro de plasma embalado plasma deficiente em atividade anticoagulante de fator v como cofator para apc uso do preparado de anticorpo preparado de proteina s preparado de | |
| DE3789310D1 (de) | Verfahren zur feststellung der entwicklungsgeschichte eines körperzustandes aus einer einzigen blutprobe. | |
| DE69124030D1 (de) | Testverfahren, die ein lösliches fibrinähnliches Monomer nutzen | |
| DE69230209D1 (de) | Reagenz zur Blutgerinnung | |
| DE60231144D1 (de) | Test für niedrigmolekulares heparin, system und reagenz dafür | |
| FI854627A7 (fi) | Menetelmä ja reagenssi plasmassa, seerumissa tai kokoveressä olevan vapaan tyroksiinin kvantitatiiviseksi määrittämiseksi. | |
| DE68917387D1 (de) | Dioxetane zur verwendung bei immuntests. | |
| ATE64470T1 (de) | Verfahren und zusammensetzungen zur bestimmung von heparin. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |